{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:30:50Z","timestamp":1787031050238,"version":"build-2736575974"},"reference-count":104,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.4158\/ep12291.ra","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T21:12:48Z","timestamp":1386709968000},"page":"500-516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBDs): What the Endocrinologist Needs to Know"],"prefix":"10.1016","volume":"20","author":[{"given":"Farhad","family":"Zangeneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart L.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Hurley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson B.","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP12291.RA_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.2003.50007","article-title":"Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey","volume":"41","author":"Coresh","year":"2003","journal-title":"Am J Kidney Dis."},{"issue":"2 suppl 1","key":"10.4158\/EP12291.RA_bb0010","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification","volume":"39","author":"National Kidney Foundation","year":"2002","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP12291.RA_bb0015","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature."},{"key":"10.4158\/EP12291.RA_bb0020","series-title":"Renal Data System: USRDS","article-title":"U.S","volume":"2004","author":"National Institutes of Health","year":"2004"},{"issue":"suppl","key":"10.4158\/EP12291.RA_bb0025","first-page":"1","article-title":"KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","journal-title":"Kidney Int."},{"key":"10.4158\/EP12291.RA_bb0030","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events","volume":"351","author":"Go","year":"2004","journal-title":"and hospitalization. N Engl J Med."},{"key":"10.4158\/EP12291.RA_bb0035","article-title":"Prevalence of undiagnosed chronic kidney disease in patients with type 2 diabetes mellitus","author":"Chen","year":"2013"},{"key":"10.4158\/EP12291.RA_bb0040","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int."},{"key":"10.4158\/EP12291.RA_bb0045","first-page":"S1","article-title":"Improving Global Outcomes (KDIGO) CKD Work Group. K\/DIGO clinical practice guideline for the diagnosis, evaluation, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","volume":"113","author":"Kidney Disease","year":"2009","journal-title":"Kidney Int Suppl."},{"key":"10.4158\/EP12291.RA_bb0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int."},{"key":"10.4158\/EP12291.RA_bb0055","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.bone.2006.12.062","article-title":"FGF23 is a hormone-regulating phosphate metabolism \u2013 unique biological characteristics of FGF23","volume":"40","author":"Fukumoto","year":"2007","journal-title":"Bone."},{"key":"10.4158\/EP12291.RA_bb0060","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/ndt\/gfn260","article-title":"The bone-renal axis in early chronic kidney disease: an emerging paradigm","volume":"23","author":"Danziger","year":"2008","journal-title":"Nephrol Dial Transplant."},{"key":"10.4158\/EP12291.RA_bb0065","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/jbmr.170","article-title":"FGF-23: more than a regulator of renal phosphate handling?","volume":"25","author":"J\u00fcppner","year":"2010","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP12291.RA_bb0070","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.ki.5002287","article-title":"Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics","volume":"74","author":"Goodman","year":"2008","journal-title":"Kidney Int."},{"key":"10.4158\/EP12291.RA_bb0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ki.1990.182","article-title":"Measurement of renal function in chronic renal disease","volume":"38","author":"Levey","year":"1990","journal-title":"Kidney Int."},{"key":"10.4158\/EP12291.RA_bb0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med."},{"key":"10.4158\/EP12291.RA_bb0085","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1742-1241.2010.02597.x","article-title":"Kidney function estimating equations in patients with chronic kidney disease","volume":"65","author":"Hojs","year":"2011","journal-title":"Int J Clin Pract."},{"key":"10.4158\/EP12291.RA_bb0090","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.1523-1755.2004.00517.x","article-title":"Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement","volume":"65","author":"Knight","year":"2004","journal-title":"Kidney Int."},{"key":"10.4158\/EP12291.RA_bb0095","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1523-1755.1999.00617.x","article-title":"Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure","volume":"56","author":"Rix","year":"1999","journal-title":"Kidney Int."},{"key":"10.4158\/EP12291.RA_bb0100","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1525-139X.2007.00319.x","article-title":"Osteoporosis and chronic kidney disease","volume":"20","author":"Gal-Moscovici","year":"2007","journal-title":"Semin Dial."},{"key":"10.4158\/EP12291.RA_bb0105","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ki.2008.264","article-title":"Chronic kidney disease and bone fracture: a growing concern","volume":"74","author":"Nickolas","year":"2008","journal-title":"Kidney Int."},{"key":"10.4158\/EP12291.RA_bb0110","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1002\/jbmr.309","article-title":"Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients","volume":"26","author":"Malluche","year":"2011","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP12291.RA_bb0115","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bmj.310.6976.358","article-title":"Effect of alfacalcidol on the natural course of renal bone disease in mild to moderate renal failure","volume":"310","author":"Hamdy","year":"1995","journal-title":"BMJ."},{"key":"10.4158\/EP12291.RA_bb0120","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1111\/j.1523-1755.2004.00972.x","article-title":"Survival following parathyroidectomy among United States dialysis patients","volume":"66","author":"Kestenbaum","year":"2004","journal-title":"Kidney Int."},{"key":"10.4158\/EP12291.RA_bb0125","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA."},{"key":"10.4158\/EP12291.RA_bb0130","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","article-title":"Relation between serum phosphate level and cardiovascular event rate in people with coronary disease","volume":"112","author":"Tonelli","year":"2005","journal-title":"Circulation."},{"key":"10.4158\/EP12291.RA_bb0135","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.02101205","article-title":"Association of disorders in mineral metabolism with progression of chronic kidney disease","volume":"1","author":"Schwarz","year":"2006","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.4158\/EP12291.RA_bb0140","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J Am Soc Nephrol."},{"key":"10.4158\/EP12291.RA_bb0145","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA."},{"key":"10.4158\/EP12291.RA_bb0150","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N Engl J Med."},{"key":"10.4158\/EP12291.RA_bb0155","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","article-title":"Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro","volume":"97","author":"Slatopolsky","year":"1996","journal-title":"J Clin Invest."},{"key":"10.4158\/EP12291.RA_bb0160","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","article-title":"Tumor-induced osteomalacia","volume":"294","author":"Jan de Beur","year":"2005","journal-title":"JAMA."},{"key":"10.4158\/EP12291.RA_bb0165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1053\/j.ajkd.2010.12.027","article-title":"Role of Klotho in aging, phosphate metabolism","volume":"58","author":"John","year":"2011","journal-title":"and CKD. Am J Kidney Dis."},{"key":"10.4158\/EP12291.RA_bb0170","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1093\/ndt\/gfr144","article-title":"Lanthanum carbonate reduces FGF23 in chronic kidney disease stage 3 patients","volume":"26","author":"Gonzalez-Parra","year":"2011","journal-title":"Nephrol Dial Transplant."},{"key":"10.4158\/EP12291.RA_bb0175","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2215\/CJN.05420709","article-title":"Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?","volume":"5","author":"Oliveira","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.4158\/EP12291.RA_bb0180","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0272-6386(04)00817-0","article-title":"Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism","volume":"44","author":"Sato","year":"2004","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP12291.RA_bb0185","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Guti\u00e9rrez","year":"2009","journal-title":"Circulation."},{"key":"10.4158\/EP12291.RA_bb0190","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00041552-200307000-00007","article-title":"Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry","volume":"12","author":"Parfitt","year":"2003","journal-title":"Curr Opin Nephrol Hypertens."},{"key":"10.4158\/EP12291.RA_bb0195","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.bone.2004.02.003","article-title":"The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis","volume":"35","author":"Sahota","year":"2004","journal-title":"Bone."},{"key":"10.4158\/EP12291.RA_bb0200","doi-asserted-by":"crossref","first-page":"432","DOI":"10.5414\/CNP62432","article-title":"High prevalence of low bone mineral density in pre-dialysis chronic kidney disease patients: bone histomorphometric analysis","volume":"62","author":"Lob\u00e3o","year":"2004","journal-title":"Clin Nephrol."},{"key":"10.4158\/EP12291.RA_bb0205","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bone.2003.05.002","article-title":"Misconceptions (3): calcium leaves bone only by resorption and enters only by formation","volume":"33","author":"Parfitt","year":"2003","journal-title":"Bone."},{"key":"10.4158\/EP12291.RA_bb0210","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/ki.1976.42","article-title":"Bone histology in incipient and advanced renal failure","volume":"9","author":"Malluche","year":"1976","journal-title":"Kidney Int."},{"key":"10.4158\/EP12291.RA_bb0215","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.4065\/83.11.1231","article-title":"Use of renal function measurements for assessing fracture risk in postmenopausal women","volume":"83","author":"McCarthy","year":"2008","journal-title":"Mayo Clin Proc."},{"key":"10.4158\/EP12291.RA_bb0220","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1210\/jc.2003-030964","article-title":"Aortic calcification and the risk of osteoporosis and fractures","volume":"89","author":"Schulz","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP12291.RA_bb0225","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/sj.ki.5000311","article-title":"Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem","volume":"69","author":"Barreto","year":"2006","journal-title":"Kidney Int."},{"key":"10.4158\/EP12291.RA_bb0230","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1053\/j.ajkd.2007.02.264","article-title":"Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis","volume":"49","author":"Jamal","year":"2007","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP12291.RA_bb0235","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1525-139X.2006.00122a.x","article-title":"Hip fractures in end-stage renal disease patients: incidence, risk factors","volume":"19","author":"Leinau","year":"2006","journal-title":"and prevention. Semin Dial."},{"key":"10.4158\/EP12291.RA_bb0240","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1210\/jc.2003-030470","article-title":"Effects of an excess and a deficiency of endogenous parathyroid hormone on volumetric bone mineral density and bone geometry determined by peripheral quantitative computed tomography in female subjects","volume":"88","author":"Chen","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP12291.RA_bb0245","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/j.ajkd.2011.04.029","article-title":"Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD","volume":"58","author":"Ure\u00f1a-Torres","year":"2011","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP12291.RA_bb0250","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/07315724.2003.10719287","article-title":"Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D","volume":"22","author":"Heaney","year":"2003","journal-title":"J Am Coll Nutr."},{"key":"10.4158\/EP12291.RA_bb0255","doi-asserted-by":"crossref","first-page":"752","DOI":"10.4065\/mcp.2010.0138","article-title":"Vitamin D deficiency in adults: when to test and how to treat","volume":"85","author":"Kennel","year":"2010","journal-title":"Mayo Clin Proc."},{"key":"10.4158\/EP12291.RA_bb0260","doi-asserted-by":"crossref","first-page":"16754","DOI":"10.1074\/jbc.M310271200","article-title":"Inactivation of the 25-hydroxyvitamin D 1\u03b1-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis","volume":"279","author":"Panda","year":"2004","journal-title":"J Biol Chem."},{"key":"10.4158\/EP12291.RA_bb0265","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1172\/JCI24742","article-title":"c-Fos protein as a target of anti-osteoclastogenic action of vitamin D","volume":"116","author":"Takasu","year":"2006","journal-title":"and synthesis of new analogs. J Clin Invest."},{"key":"10.4158\/EP12291.RA_bb0270","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1359\/jbmr.060714","article-title":"Vitamin D action and regulation of bone remodeling: suppression of osteoclastogenesis by the mature osteoblast","volume":"21","author":"Baldock","year":"2006","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP12291.RA_bb0275","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/978-1-4684-7758-0_44","article-title":"Pathogenesis of renal osteodystrophy: roles of phosphate and skeletal resistance to PTH","volume":"103","author":"Ritz","year":"1978","journal-title":"Adv Exp Med Biol."},{"key":"10.4158\/EP12291.RA_bb0280","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure\u2013an evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int."},{"key":"10.4158\/EP12291.RA_bb0285","first-page":"135","article-title":"Adynamic bone disease \u2013 bone and beyond","volume":"3","author":"Brandenburg","year":"2008","journal-title":"NDT Plus."},{"key":"10.4158\/EP12291.RA_bb0290","first-page":"S62","article-title":"Risk of adynamic bone disease in dialyzed patients","volume":"38","author":"Malluche","year":"1992","journal-title":"Kidney Int Suppl."},{"key":"10.4158\/EP12291.RA_bb0295","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/ki.1994.380","article-title":"Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy","volume":"46","author":"Goodman","year":"1994","journal-title":"Kidney Int."},{"key":"10.4158\/EP12291.RA_bb0300","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","article-title":"Arterial calcifications and bone histomorphometry in end-stage renal disease","volume":"15","author":"London","year":"2004","journal-title":"J Am Soc Nephrol."},{"key":"10.4158\/EP12291.RA_bb0305","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1681\/ASN.2006101089","article-title":"Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients","volume":"19","author":"Ferreira","year":"2008","journal-title":"J Am Soc Nephrol."},{"key":"10.4158\/EP12291.RA_bb0310","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/sj.ki.5001666","article-title":"Reversal of adynamic bone disease by lowering of dialysate calcium","volume":"70","author":"Haris","year":"2006","journal-title":"Kidney Int."},{"key":"10.4158\/EP12291.RA_bb0315","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.bone.2007.06.014","article-title":"Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium","volume":"41","author":"Spasovski","year":"2007","journal-title":"Bone."},{"key":"10.4158\/EP12291.RA_bb0320","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1002\/jbmr.126","article-title":"Increased osteocyte death and mineralization inside bone after parathyroidectomy in patients with secondary hyperparathyroidism","volume":"25","author":"Yajima","year":"2010","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP12291.RA_bb0325","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5002769","article-title":"K\/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients","volume":"73","author":"Barreto","year":"2008","journal-title":"Kidney Int."},{"key":"10.4158\/EP12291.RA_bb0330","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: a systematic review","volume":"17","author":"Tonelli","year":"2006","journal-title":"J Am Soc Nephrol."},{"key":"10.4158\/EP12291.RA_bb0335","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1053\/j.ajkd.2010.07.016","article-title":"Prediction of ESRD and death among people with CKD: The Chronic Renal Impairment in Birmingham (CRIB) prospective cohort study","volume":"56","author":"Landray","year":"2010","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP12291.RA_bb0340","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1046\/j.1523-1755.2003.00837.x","article-title":"Total hip bone mass predicts survival in chronic hemodialysis patients","volume":"63","author":"Taal","year":"2003","journal-title":"Kidney Int."},{"key":"10.4158\/EP12291.RA_bb0345","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s002239900419","article-title":"Osteoporosis and coronary atherosclerosis in asymptomatic post-menopausal women","volume":"62","author":"Barengolts","year":"1998","journal-title":"Calcif Tissue Int."},{"key":"10.4158\/EP12291.RA_bb0350","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/ndt\/gfg595","article-title":"Effects of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure","volume":"19","author":"Rix","year":"2004","journal-title":"Nephrol Dial Transplant."},{"key":"10.4158\/EP12291.RA_bb0355","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1359\/JBMR.050817","article-title":"Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials","volume":"20","author":"Miller","year":"2005","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP12291.RA_bb0360","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1359\/jbmr.070112","article-title":"Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial","volume":"22","author":"Jamal","year":"2007","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP12291.RA_bb0365","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1681\/ASN.2007050555","article-title":"The effect of raloxifene treatment in postmenopausal women with CKD","volume":"19","author":"Ishani","year":"2008","journal-title":"J Am Soc Nephrol."},{"key":"10.4158\/EP12291.RA_bb0370","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00198-006-0189-8","article-title":"Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment","volume":"18","author":"Miller","year":"2007","journal-title":"Osteoporos Int."},{"key":"10.4158\/EP12291.RA_bb0375","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/jbmr.403","article-title":"Effects of denosumab on fracture and bone mineral density by level of kidney function","volume":"26","author":"Jamal","year":"2011","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP12291.RA_bb0380","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ki.1994.30","article-title":"Effects of oral calcitriol on bone mineral density in patients with end-stage renal failure","volume":"45","author":"Ruedin","year":"1994","journal-title":"Kidney Int."},{"key":"10.4158\/EP12291.RA_bb0385","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1055\/s-2003-39483","article-title":"Effect of parathyroidectomy on bone mineral density in hemodialysis patients with secondary hyperparathyroidism: possible usefulness of preoperative determination of parathyroid hormone level for prediction of bone regain","volume":"35","author":"Yano","year":"2003","journal-title":"Horm Metab Res."},{"key":"10.4158\/EP12291.RA_bb0390","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3949\/ccjm.76a.08108","article-title":"Fragility fractures in chronic kidney disease: an opinion-based approach","volume":"76","author":"Miller","year":"2009","journal-title":"Cleveland Clin J Med."},{"key":"10.4158\/EP12291.RA_bb0395","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00198-011-1781-0","article-title":"Fracture risk assessment in patients with chronic kidney disease","volume":"23","author":"Jamal","year":"2012","journal-title":"Ostoporosis Int."},{"key":"10.4158\/EP12291.RA_bb0400","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1440-1797.2010.01288.x","article-title":"Using vertebral bone densitometry to determine aortic calcification in patients with chronic kidney disease","volume":"15","author":"Toussaint","year":"2010","journal-title":"Nephrology (Carlton)."},{"key":"10.4158\/EP12291.RA_bb0405","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1525-139X.2009.00650.x","article-title":"A rational guide to reducing fracture risk in dialysis patients","volume":"23","author":"Toussaint","year":"2010","journal-title":"Sem Dial."},{"key":"10.4158\/EP12291.RA_bb0410","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00774-008-0030-x","article-title":"Determinants of prevalent vertebral fractures and progressive bone loss in long-term hemodialysis patients","volume":"27","author":"Mares","year":"2009","journal-title":"J Bone Miner Metab."},{"key":"10.4158\/EP12291.RA_bb0415","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","article-title":"Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone","volume":"36","author":"Coco","year":"2000","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP12291.RA_bb0420","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","article-title":"the risks for hip, vertebral, and pelvic fractures among patients on dialysis","volume":"47","author":"Danese","year":"2006","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP12291.RA_bb0425","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1681\/ASN.2007010022","article-title":"Fracture risk after parathyroidectomy among chronic hemodialysis patients","volume":"18","author":"Rudser","year":"2007","journal-title":"J Am Soc Nephrol."},{"key":"10.4158\/EP12291.RA_bb0430","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1359\/jbmr.060105","article-title":"Cortical pQCT measures are associated with fractures in dialysis patients","volume":"21","author":"Jamal","year":"2006","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP12291.RA_bb0435","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/j.ajkd.2010.02.338","article-title":"Management of osteoporosis in CKD stages 3 to 5","volume":"55","author":"Gordon","year":"2010","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP12291.RA_bb0440","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1359\/JBMR.041221","article-title":"Decrease in thoracic vertebral bone attenuation with calcium-based phosphate binders in hemodialysis","volume":"20","author":"Raggi","year":"2005","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP12291.RA_bb0445","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1053\/j.ajkd.2010.06.011","article-title":"Outcomes associated with phosphorus binders in men with non-dialysis-dependent chronic kidney disease","volume":"56","author":"Kovesdy","year":"2010","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP12291.RA_bb0450","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/ki.2011.490","article-title":"Calcium balance in normal individuals and in patients with chronic kidney disease on low-and high-calcium diets","volume":"81","author":"Spiegel","year":"2012","journal-title":"Kidney Int."},{"key":"10.4158\/EP12291.RA_bb0455","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMra0912522","article-title":"Oral phosphate binders in patients with kidney failure","volume":"362","author":"Tonelli","year":"2010","journal-title":"N Engl J Med."},{"issue":"suppl 1","key":"10.4158\/EP12291.RA_bb0460","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.2215\/CJN.05860809","article-title":"Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population","volume":"5","author":"West","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.4158\/EP12291.RA_bb0465","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4065\/mcp.2010.0567","article-title":"Vitamin D insufficiency","volume":"86","author":"Thacher","year":"2011","journal-title":"Mayo Clin Proc."},{"key":"10.4158\/EP12291.RA_bb0470","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ki.2010.113","article-title":"Use of vitamin D in chronic kidney disease patients","volume":"78","author":"Gal-Moscovici","year":"2010","journal-title":"Kidney Int."},{"key":"10.4158\/EP12291.RA_bb0475","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1053\/j.ajkd.2005.10.007","article-title":"Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD","volume":"47","author":"Coyne","year":"2006","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP12291.RA_bb0480","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1046\/j.1523-1755.2003.00878.x","article-title":"Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism","volume":"63","author":"Sprague","year":"2003","journal-title":"Kidney Int."},{"key":"10.4158\/EP12291.RA_bb0485","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1053\/j.ajkd.2004.01.012","article-title":"Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4","volume":"43","author":"Coburn","year":"2004","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP12291.RA_bb0490","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med."},{"key":"10.4158\/EP12291.RA_bb0495","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature."},{"key":"10.4158\/EP12291.RA_bb0500","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jocd.2008.02.002","article-title":"Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases","volume":"11","author":"Delmas","year":"2008","journal-title":"J Clin Densitom."},{"key":"10.4158\/EP12291.RA_bb0505","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/jbmr.1613","article-title":"Padhi D. A singledose study of denosumab in patients with various degrees of renal impairment","volume":"27","author":"Block","year":"2012","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP12291.RA_bb0510","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/jbmr.389","article-title":"Relationships between calcified atherosclerotic plaque and bone mineral density in African Americans with type 2 diabetes","volume":"26","author":"Divers","year":"2011","journal-title":"J Bone Miner Res."},{"key":"10.4158\/EP12291.RA_bb0515","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1053\/j.ajkd.2008.09.021","article-title":"A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet HCl in participants with CKD not receiving dialysis","volume":"53","author":"Chonchol","year":"2009","journal-title":"Am J Kidney Dis."},{"key":"10.4158\/EP12291.RA_bb0520","first-page":"801","article-title":"Experience with cinacalcet for secondary hyperparathyroidism in patients with chronic kidney disease stage III and IV","volume":"1","author":"Forslund","year":"2009","journal-title":"Clin Med Thera."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20421767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20421767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/575144X75632R08Q.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:56:53Z","timestamp":1761515813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20421767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":104,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S1530891X20421767"],"URL":"https:\/\/doi.org\/10.4158\/ep12291.ra","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBDs): What the Endocrinologist Needs to Know","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP12291.RA","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}